World Clinical Biomarkers (CB) and CDx Europe 2019

10th World Clinical Biomarkers (CB) and CDx Europe is organized by Hanson Wade and will be held from Apr 15 - 17, 2019 at The Waldorf Hilton, London, London, England, United Kingdom.

Description:
For its 10th year anniversary, Clinical Biomarkers and World CDx Europe is back to help the biomarker, diagnostic and precision medicine community translate clinically predictive biomarkers into proven IVDs to advance the standard of personalized care. Built for biomarker, translational, clinical, regulatory and commercial functions, Clinical Biomarkers and World CDx Europe is your end-to-end meeting for translating exploratory signatures into clinical useful biomarkers and overcoming key bottlenecks to driving adoption and access to game-changing diagnostic-enabled precision medicines.

Key topics for 2019:
• Identifying Truly Predictive Biomarkers. Evolving strategies for contextualizing and identifying truly predictive biomarker signatures.
• Clinical Biomarkers. Building the clinical studies to generate robust evidence to demonstrate the utility of biomarkers to support candidate development and approval registration.
• Universal Panel Diagnostics. Standardizing and deploying a new era of universal panel diagnostics to improve the identification and implementation of biomarkers and accelerate precision medicine deployment in the healthcare setting.
• European IVDR. Translating guidance into action: Understanding the impact of the new IVDR on a fractional European landscape and how to best build a safeguarded biomarker and diagnostic strategy for the future.

Speakers: Gerard Sanderink (Sanofi), Joanne Hackett (Genomics England), Claudia Dollins (Merck KGaA), Sarah Byron (NICE), Magdalena Zajac (AstraZeneca), Hugues Malonne (Federal Agency for Medicines and Health Products)

Time: 8:00 am to 2:30 pm